{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:33:06Z","timestamp":1788870786266,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":770,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Associazione Italiana contro le Leucemie, Linfomi e Mieloma"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bbmt.2012.11.015","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T08:06:27Z","timestamp":1354003587000},"page":"495-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation by Donor Graft CD3+\/Tregs Ratio: A Single-Center Experience"],"prefix":"10.1016","volume":"19","author":[{"given":"Mario","family":"Delia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mestice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Carluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommasina","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Sgherza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Specchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2012.11.015_bib1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2007-07-103895","article-title":"The impact of regulatory T cells on T-cell immunity following hemtopoietic cell transplantation","volume":"11","author":"Nguyen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2012.11.015_bib3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1084\/jem.189.8.1329","article-title":"The effect of graft-versus-host disease on\u00a0T cell production and homeostasis","volume":"189","author":"Dulude","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2012.11.015_bib4","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.4049\/jimmunol.140.9.2970","article-title":"Immunodeficiency in graft-versus-host disease: mechanism of immune suppression","volume":"140","author":"Wall","year":"1988","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2012.11.015_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1083-8791(99)70011-X","article-title":"Pathophysiologic mechanisms of graft-versus-host-disease","volume":"5","author":"Ferrara","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.11.015_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft-versus-host disease by inactivation of host antigen presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2012.11.015_bib7","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood-2004-03-1040","article-title":"Association of Foxp3 regulatory gene expression with acute graft-versus-host disease","volume":"104","author":"Miura","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbmt.2005.11.002","article-title":"Modulation of graft-versus-host disease: role of regulatory T\u00a0lymphocytes","volume":"12","author":"Hess","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.11.015_bib9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbmt.2011.10.039","article-title":"CD3+\/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation","volume":"18","author":"Pastore","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.11.015_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after\u00a0allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2012.11.015_bib11","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex\u00a0vivo activated and expanded CD4+\/CD25+ immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-065X.1997.tb01030.x","article-title":"Thymic aging and T-cell regeneration","volume":"160","author":"Mackall","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2012.11.015_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V66.3.664.664","article-title":"Effects on in\u00a0vitro depletion of T cells in HLA-identical allogeneic marrow graft","volume":"66","author":"Martin","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0198-8859(90)90071-V","article-title":"Effect of HLA incompatibility on\u00a0graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma","volume":"29","author":"Anasetti","year":"1990","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2012.11.015_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow HLA matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.11.015_bib18","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbmt.2010.04.011","article-title":"Recovery of CMV-specific CD8+ T\u00a0cells and Tregs after allogeneic peripheral blood stem cell transplantation","volume":"17","author":"Pastore","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.11.015_bib20","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1002\/cncr.24531","article-title":"Risk score for outcome after allogeneic hematopoietic stem cell transplantation","volume":"115","author":"Gratwohl","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2012.11.015_bib21","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in\u00a0adults with acute myelogenous leukemia","volume":"119","author":"Saber","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2012-03-414573","article-title":"Validation of the hematopoietic cell transplantation-specific comorbidity index: a prospective, multicenter GITMO study","volume":"120","author":"Raimondi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib23","first-page":"663","article-title":"Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation","volume":"15","author":"Eisner","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.11.015_bib24","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1182\/blood-2006-12-041889","article-title":"How I treat refractory acute GVHD","volume":"109","author":"Deeg","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib25","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/blood-2005-12-4851","article-title":"Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day\u00a0+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin","volume":"107","author":"Van Lint","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood.V77.8.1821.1821","article-title":"A\u00a0retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment","volume":"77","author":"Martin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/bbmt.2002.v8.pm11939605","article-title":"Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment","volume":"8","author":"Arai","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.11.015_bib28","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2012.11.015_bib29","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.bbmt.2012.06.014","article-title":"Graft-versus-Host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning","volume":"18","author":"Weisdorf","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.11.015_bib30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","article-title":"High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT","volume":"108","author":"Rezvani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.11.015_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/01.tp.0000260140.04815.77","article-title":"Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell","volume":"83","author":"Wolf","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.11.015_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cyto.a.22061","article-title":"Allogeneic bone marrow grafts with high levels of CD4+CD25+FoxP3+T cells can lead to engraftment failure","volume":"81","author":"Fricke","year":"2012","journal-title":"Cytometry Part A"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911200523X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911200523X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:47:01Z","timestamp":1761058021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387911200523X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S108387911200523X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.11.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation by Donor Graft CD3+\/Tregs Ratio: A Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}